MKL1 deficiency results in a severe neutrophil motility defect due to impaired actin polymerization.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
11 06 2020
Historique:
received: 26 07 2019
accepted: 18 02 2020
pubmed: 5 3 2020
medline: 9 2 2021
entrez: 5 3 2020
Statut: ppublish

Résumé

Megakaryoblastic leukemia 1 (MKL1) promotes the regulation of essential cell processes, including actin cytoskeletal dynamics, by coactivating serum response factor. Recently, the first human with MKL1 deficiency, leading to a novel primary immunodeficiency, was identified. We report a second family with 2 siblings with a homozygous frameshift mutation in MKL1. The index case died as an infant from progressive and severe pneumonia caused by Pseudomonas aeruginosa and poor wound healing. The younger sibling was preemptively transplanted shortly after birth. The immunodeficiency was marked by a pronounced actin polymerization defect and a strongly reduced motility and chemotactic response by MKL1-deficient neutrophils. In addition to the lack of MKL1, subsequent proteomic and transcriptomic analyses of patient neutrophils revealed actin and several actin-related proteins to be downregulated, confirming a role for MKL1 as a transcriptional coregulator. Degranulation was enhanced upon suboptimal neutrophil activation, whereas production of reactive oxygen species was normal. Neutrophil adhesion was intact but without proper spreading. The latter could explain the observed failure in firm adherence and transendothelial migration under flow conditions. No apparent defect in phagocytosis or bacterial killing was found. Also, monocyte-derived macrophages showed intact phagocytosis, and lymphocyte counts and proliferative capacity were normal. Nonhematopoietic primary fibroblasts demonstrated defective differentiation into myofibroblasts but normal migration and F-actin content, most likely as a result of compensatory mechanisms of MKL2, which is not expressed in neutrophils. Our findings extend current insight into the severe immune dysfunction in MKL1 deficiency, with cytoskeletal dysfunction and defective extravasation of neutrophils as the most prominent features.

Identifiants

pubmed: 32128589
pii: S0006-4971(20)61960-7
doi: 10.1182/blood.2019002633
doi:

Substances chimiques

MRTFA protein, human 0
MRTFB protein, human 0
Trans-Activators 0
Transcription Factors 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2171-2181

Informations de copyright

© 2020 by The American Society of Hematology.

Auteurs

Evelien G G Sprenkeler (EGG)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.
Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, AUMC, University of Amsterdam, Amsterdam, The Netherlands.

Stefanie S V Henriet (SSV)

Department of Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Anton T J Tool (ATJ)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Iris C Kreft (IC)

Department of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam, The Netherlands.

Ivo van der Bijl (I)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Cathelijn E M Aarts (CEM)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Michel van Houdt (M)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Paul J J H Verkuijlen (PJJH)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Koen van Aerde (K)

Department of Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Gerald Jaspers (G)

Department of Pediatric Intensive Care and.

Arno van Heijst (A)

Department of Neonatology, Amalia Children's Hospital, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Wouter Koole (W)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Thatjana Gardeitchik (T)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Judy Geissler (J)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Martin de Boer (M)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Simon Tol (S)

Department of Research Facilities and.

Christine W Bruggeman (CW)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Floris P J van Alphen (FPJ)

Department of Research Facilities and.

Han J M P Verhagen (HJMP)

Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.

Emile van den Akker (E)

Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.

Hans Janssen (H)

Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands; and.

Robin van Bruggen (R)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.

Timo K van den Berg (TK)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.
Department of Molecular Cell Biology and Immunology, AUMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Kian D Liem (KD)

Department of Neonatology, Amalia Children's Hospital, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Taco W Kuijpers (TW)

Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, The Netherlands.
Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, AUMC, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH